
What We Do
Parimer is a U.S.-based Contract Development and Manufacturing Organization (CDMO)
We partner with scientists, startups, and research teams to bring high-potential ideas to market.
From early-stage R&D to scalable manufacturing, we support the entire product lifecycle with chemical process development, analytical support, and small-to-mid-scale production.
​
Our clients choose Parimer when speed matters, when quality can't be compromised, and when off-the-shelf solutions just won’t cut it. We don’t just manufacture—we help our partners move faster, make smarter decisions, and build with confidence.

OUR HISTORY
Parimer Scientific is an independent, American-owned, and operated private scientific service laboratory that was started in 2018. Today, Parimer is best classified as a Drug Substance CDMO that supports dozens of clients in their efforts to get new molecules and treatments to those in need.
Parimer has no shareholders, private equity interests, or other profit-driven parties beyond the chemists and engineers employed in the company's operations. This organizational structure allows Parimer to remain highly competitive against more corporate and executive-heavy competitors.
Proudly U.S.-Based
Powering Global Change
Parimer is a U.S.-based drug development company, we help companies navigate the complexities of bringing a drug to market and achieving FDA compliance.
​
​Our U.S.-based operations ensure high-quality manufacturing, regulatory compliance, and efficient processes, enabling us to drive innovation and create lasting impact in biotech, pharmaceuticals, and advanced materials.



Meet the Scientists

Richard T. Pace, PhD
Owner and Principle Scientist
Dr. Pace is the founder and principal scientist of Parimer Scientific.
Has worked in research, development and manufacturing of medical devices, polymers and drug substances for nearly 20 years.
​
Dr. Pace is both a bioengineer and chemical engineer.
​
​

M. Victoria Pruitt, PhD
Quality Director and Senior Scientist
Dr. Pruitt is an analytical chemist with nearly a decade of experience in developing & running regulated quality control systems.
She has writte many of Parimer's systems from scratch & defended them through dozens of audits from regulatory bodies such as FDA, DEA & ISO.
​

Sean Spurlin, PhD
Project Manager and Lead Synthetic Chemist
Dr. Spurlin is a total synthetic organic chemist with experience in a wide variety of complex chemical manufacturing including compounds, intermediates and impurities.
Today Spurlin serves as a project manager who oversees Parimer's chemical development and manufacturing projects.

Alex Kullman, MS
Project Manager and Pharmaceutical Scientist
Mr. Kullman is a bioengineer and computational biologist serving as a project manager at Parimer for our bio-based projects.
He has BS in Bioengineering with a minor in chemistry from Clemson University and academic project experience using Python, Go, MATLAB, FE Bio, and SOLIDWORKS.​​
​
Why Parimer
Speed. Quality. Flexibility
We are not your typical CDMO, we are:
​
Lean, responsive operations with rapid turnaround
​
Fully U.S.-based team and facilities
​
Custom development and small-batch production
​
Transparent collaboration—no black box manufacturing
​
We don't just execute a process - we build it with you.



























Who We Work With
University researchers advancing lab discoveries
​
​Startups launching new chemical products
​
Mid-size companies needing custom formulation or scale-up
​
Government and defense agencies requiring secure, high-integrity manufacturing
Our Services
From Bench to Batch Production
Parimer offers integrated support across:
​Chemical Process Development
​
Analytical Method Development & Validation
​
Small to Mid-Scale Manufacturing
​
Regulatory Documentation Support
​
Custom Formulation & Problem-Solving

